The President of an American biosciences company has applauded the University of Leicester for its work into ground-breaking identification of new treatment for infectious hospital bugs.
Phil Young, from AmpliPhi Biosciences Corporation, also commented on his excitement at working with Dr Martha Clokie, the lead scientist at the university.
We are very excited about this partnership with Dr Clokie and the University of Leicester. Phage-based therapy has the potential to revolutionise the way C diff infections are treated in the clinic, in compliance with the regulatory frameworks already in place. We firmly believe that this collaboration may result in a treatment that could benefit patients, clinicians and health-care organisations alike.
More top news
A giant statue of Mansfield swimmer Rebecca Adlington has been unveiled in London ahead of the Rio Olympics.
Nottinghamshire Wildlife Trust have been working to help otters return to their former home since the late 1990s.
More than 130,000 people in the Midlands are living with dementia, and around 5% of them are under the age of 65.